期刊文献+

安非他酮对抑郁症患者血清性激素的影响 被引量:1

下载PDF
导出
摘要 目的:探讨安非他酮对抑郁症患者血清性激素的影响。方法:用放免法测定42例抑郁症患者治疗前和治疗后1、6周末血清催乳素(PRL)、促滤泡成熟激素(FSH)、促黄体生成素(LH)、睾酮(T)、雌二醇(E2)差异,并与30例健康者对照。结果:抑郁症组男性LH、E2和女性PRL、FSH与对照组比较明显升高。治疗后1、6周末男性患者PRL、T、E2和女性PRL、T与治疗前差异有显著性。结论:抑郁症患者存在下丘脑-垂体-性腺轴内分泌异常,安非他酮可引起抑郁症患者性激素分泌变异。
出处 《实用医学杂志》 CAS 2007年第24期3941-3942,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献5

二级参考文献8

  • 1郭田生,杨玲玲.芬氟拉明在精神医学中的应用[J].国外医学(精神病学分册),1996,23(1):10-14. 被引量:3
  • 2郭田生,杨玲玲,李小玲,徐增毅,刘磊.精神分裂症d-芬氟拉明激发的神经内分泌反应与临床症状的关系[J].中国神经精神疾病杂志,1996,22(6):327-330. 被引量:3
  • 3杨权,中华神经精神科杂志,1984年,17卷,278页
  • 4TOMARKEN AJ,DICHTER GS,FREID C,et al.Assessing the effects of bupropion SR on mood dimensions of depression[J].J Affect Disord,2004,78 (3):235-241.
  • 5SETTLE EC,STAHL SM,BATEY SR,et al.Safety profile of sustained-release bupropion in depression:results of three clinical trials[J].Clin Ther,1999,21 (3):454-463.
  • 6NIEUWSTRATEN CE,DOLOVICH LR.Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression[J].Ann Pharmacother,2001,35 (12):1608-1613.
  • 7GLOD CA,LYNCH A,FLYNN E,et al.Open trial of bupropion SR in adolescent major depression[J].J Child Adolesc Psychiatr Nurs,2003,16(3):123-130.
  • 8JAMERSON BD,KRISHNAN KR,ROBERTS J,et al.Effect of bupropion SR on specific symptom clusters of depression:analysis of the 31-item Hamilton Rating Scale for depression[J].Psychopharmacol Bull,2003,37(2):67 -78.

共引文献31

同被引文献24

  • 1王雪,张波,李静,孙学礼.盐酸安非他酮缓释片治疗抑郁症的双盲双模拟随机对照试验[J].中国循证医学杂志,2007,7(6):409-414. 被引量:9
  • 2Wilkes S. Bupropion [J]. Drugs Today (Barc), 2006, 42 (10): 671-681.
  • 3Jamerson B D, Krishnan K R, Roberts J, et al. Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31- item Hamilton Rating Scale for depression [J]. Psychopharmacol Bull, 2003,37 (2) : 67-78.
  • 4Thase M E, Haight B R, Richard N, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials [ J ]. J Clin Psychiatry, 2005, 66 (8) : 974-981.
  • 5Hewett K, Chrzanowski W, Schmitz M, et al. Eight-week, placebocontrolled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR [J]. J Psychopharmacol, 2009, 23(5): 531-538.
  • 6Papakostas G I, Trivedi M H, Alpert J E, et al. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a metaanalysis of individual patient data from 10 double-blind, randomized clinical trials [J]. J Psychiatr Res, 2008, 42(2) : 134-140.
  • 7John R A, Madhukar H, Trivedi M D, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression [J]. N Engl J Med, 2006, 354(12) : 1231-1242.
  • 8Zisook S, Rush A J, Haight B R, et al. Use of bupropion in combination with serotonin reuptake inhibitors [J]. Biol Psychiatry, 2006, 59(3): 203-210.
  • 9Gabriele S, Levefich L L, Ahshuler M A, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers [J]. Am J Psychiatry, 2006, 163(2) :232- 239.
  • 10Post R M, Ahshuler L L, Leverich G S, et al. Mood switch in bipolar depression : comparison of adjunctive venlafaxine, bupropion and sertraline [J]. Br J Psychiatry, 2006, 189(2) : 124 -131.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部